Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Cabel

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
JAMA Oncology|November 5, 2020
Efficacy of Circulating Tumor Cell Count-Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: The STIC CTC Randomized Clinical TrialFrançois-Clément Bidard, William Jacot, Nicolas Kiavue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2024
Noninvasive Multicancer Detection Using DNA Hypomethylation of LINE-1 RetrotransposonsMarc Michel, Maryam Heidary, Anissa Mechri, et al.
European Urology|October 23, 2022
FGFR3 Mutational Activation Can Induce Luminal-like Papillary Bladder Tumor Formation and Favors a Male Sex BiasMing-Jun Shi, Jacqueline Fontugne, Aura Moreno-Vega, et al.
Iscience|March 19, 2026
CMV seropositivity associates with poor clinical outcome in triple negative breast cancerRomain-David Seban, Constance Lamy, Luc Cabel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2024
Plasma ctDNA as a Treatment Response Biomarker in Metastatic Cancers: Evaluation by the RECIST Working GroupAlexander W Wyatt, Saskia Litiere, Francois-Clément Bidard, et al.
Oral Oncology|November 29, 2024
Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic resectable head and neck squamous cell carcinoma using circulating tumor DNAGrégoire Marret, Constance Lamy, Sophie Vacher, et al.
BMC Cancer|February 4, 2026
SCANDARE: an institutional dynamic prospective interventional biobanking studyConstance Lamy, Léonard Laurent, Olivier Choussy, et al.
Critical Reviews in Oncology/Hematology|February 18, 2019
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paperMassimo Cristofanilli, Jean-Yves Pierga, James Reuben, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
JAMA Oncology|November 5, 2020
Efficacy of Circulating Tumor Cell Count-Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: The STIC CTC Randomized Clinical TrialFrançois-Clément Bidard, William Jacot, Nicolas Kiavue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2024
Noninvasive Multicancer Detection Using DNA Hypomethylation of LINE-1 RetrotransposonsMarc Michel, Maryam Heidary, Anissa Mechri, et al.
European Urology|October 23, 2022
FGFR3 Mutational Activation Can Induce Luminal-like Papillary Bladder Tumor Formation and Favors a Male Sex BiasMing-Jun Shi, Jacqueline Fontugne, Aura Moreno-Vega, et al.
Iscience|March 19, 2026
CMV seropositivity associates with poor clinical outcome in triple negative breast cancerRomain-David Seban, Constance Lamy, Luc Cabel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2024
Plasma ctDNA as a Treatment Response Biomarker in Metastatic Cancers: Evaluation by the RECIST Working GroupAlexander W Wyatt, Saskia Litiere, Francois-Clément Bidard, et al.
Oral Oncology|November 29, 2024
Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic resectable head and neck squamous cell carcinoma using circulating tumor DNAGrégoire Marret, Constance Lamy, Sophie Vacher, et al.
BMC Cancer|February 4, 2026
SCANDARE: an institutional dynamic prospective interventional biobanking studyConstance Lamy, Léonard Laurent, Olivier Choussy, et al.
Critical Reviews in Oncology/Hematology|February 18, 2019
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paperMassimo Cristofanilli, Jean-Yves Pierga, James Reuben, et al.
Pageof 8